Industry Profile
Cell Therapy
Target researchers — Immunologists, cell biologists, and molecular biologists with expertise in CAR-T engineering, allogeneic cell manufacturing, T-cell receptor therapy, stem cell differentiation, and GMP cell production
Cell therapy engineers living cells—predominantly T cells and NK cells—as therapeutic agents, with CAR-T programs for hematological cancers leading commercial adoption. The field recruits immunology and gene-editing PhDs and relies on university labs for novel receptor discovery, ipsc differentiation, and manufacturing process research.
Key Companies
Use Cases
CAR construct licensing
iPSC differentiation protocol partnerships
Gene editing tool procurement
Cell manufacturing scale-up consulting
Viral vector supply contracts
T-cell engineering co-development
Free to browse · subscribe to unlock the full dataset
See the full dataset.
Create a free account to search every researcher, set alerts, and export verified contacts to CSV / API.
Sign Up Free →